Metabolic syndrome in stable long-term antipsychotic monotherapy and polypharmacy among patients with schizophrenia: a real-world comparative study. [PDF]
Usta H, Beşikci Keleş D.
europepmc +1 more source
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]
Nehme H +6 more
europepmc +1 more source
Beyond Weight Loss: Glucagon-Like Peptide-1 Receptor Agonists and Antipsychotic Adherence in Schizophrenia. [PDF]
López-Ibor I, Humphery H, Tafet G.
europepmc +1 more source
Objective: To determine whether the use of risperidone in a US managed-care environment is associated with a reduction in the use of mental healthcare services.
Ramy Mahmoud +3 more
core
Treatment-Resistant Psychosis in an Adolescent at Risk of Metabolic Syndrome: A Case Report. [PDF]
Belkin M, Grewal J.
europepmc +1 more source
Potential Role of the Triple Receptor Agonist Retatrutide in Antipsychotic-Associated Metabolic Dysfunction Among Clozapine- and Olanzapine-Treated Schizophrenia Spectrum Disorders: A Narrative Review and Theoretical Framework. [PDF]
Kaczynski MM +4 more
europepmc +1 more source
Gut microbiota-derived ergothioneine: a promising neuroprotective metabolite against antipsychotic-induced cognitive decline. [PDF]
Cao JW, Fan Z, Wang X.
europepmc +1 more source
Antipsychotic Prescriptions for Prenatal and Postpartum Women in Japan: A Large Claims Database Study. [PDF]
Obara R +16 more
europepmc +1 more source
Antipsychotic-Induced Remodeling of the Gut Microbiota: Drug-Specific Patterns and Molecular Links to Metabolic Adverse Effects. [PDF]
Papacocea RI +4 more
europepmc +1 more source
Risperidone-induced severe hypothermia in an elderly woman with possible prior quetiapine-associated hypothermia tolerating aripiprazole: A case report and literature review. [PDF]
Seguin A +3 more
europepmc +1 more source

